TCL Archive Yervoy-Nivolumab Combination Treatment Shrinks Tumors 80 Percent in Three Months May 31, 2013
TCL Archive ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk August 2, 1991